- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
T1EV34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Teva Pharmaceutical Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
86.67 BRL
-0.3%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 3.5% above the Trend Line and sits at 80.2% of its 52-week range. The latest completed week returned -0.3%, after a -2.9% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
45
out of 100
Latest Close
86.67 BRL
7 Aug 2026
1W Return
-0.3%
latest completed week
4W Return
-2.9%
short-term follow-through
12W Return
-3.1%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
0.0x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 3 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.3%
Latest completed week; four-week move -2.9%.
Indicator stack
52/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 3.5% above the Trend Line and sits at 80.2% of its 52-week range. The latest completed week returned -0.3%, after a -2.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5412-week average 0.49
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.54Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.9% over four weeks, -3.1% over 12 weeks, and 99.1% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.16Latest activity-pressure read.
Pressure change-139.9%Four-week change in activity pressure.
Leadership12.89Latest relative-leadership reading.
RS change-18.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 4 relevant articles.
1 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.9%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher5 of 2613 weeks finished lower.
Best week+15.8%Week of 8 May.
Worst week-9.4%Week of 13 Mar.
Latest week-0.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains1
Flat weeks8
Modest losses9
Sharp losses4
Recent vol4.8%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split21/21Count of positive and negative weeks in the 52-week window.
Average skew6.5% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank53 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Drug Manufacturers - Specialty & Generic
4-week rank4 / 9
Group average-2.9%
Trend breadth22.2%
Trend22.2%active weekly trend signals
MD33.3%positive activity pressure
RS44.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape47/100
Trend, activity pressure, participation, and risk combine to a 47/100 tape read.
Indicator analysis56/100Latest 12-week confirmation: trend 7/12, activity pressure 6/12, relative leadership 12/12.
Activity pressure 0.54; 3 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 4 relevant articles.
Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 86.67 BRL | -0.3% | 83.77 BRL | 52.18 BRL | -0.16 | 12.89 | 1 | On |
| 31 Jul 2026 | 86.95 BRL | 11.6% | 83.76 BRL | 51.75 BRL | 0.03 | 10.64 | 4 | Off |
| 24 Jul 2026 | 77.93 BRL | -4.1% | 83.64 BRL | 51.32 BRL | 0.17 | 2.16 | 2.0K | Off |
| 17 Jul 2026 | 81.30 BRL | -8.9% | 83.86 BRL | 50.96 BRL | 0.31 | 7.27 | 7 | Off |
| 10 Jul 2026 | 89.28 BRL | 0.0% | 83.97 BRL | 50.57 BRL | 0.41 | 15.75 | 0 | On |
| 3 Jul 2026 | 89.28 BRL | 3.8% | 83.68 BRL | 50.12 BRL | 0.23 | 19.01 | 0 | Off |
| 26 Jun 2026 | 85.99 BRL | 0.0% | 83.23 BRL | 49.67 BRL | 0.04 | 16.24 | 0 | Off |
| 19 Jun 2026 | 85.99 BRL | 4.9% | 82.65 BRL | 49.23 BRL | -0.04 | 20.33 | 0 | On |
| 12 Jun 2026 | 81.96 BRL | 0.0% | 81.98 BRL | 48.80 BRL | -0.13 | 13.79 | 0 | On |
| 5 Jun 2026 | 81.96 BRL | -5.1% | 81.55 BRL | 48.39 BRL | -0.11 | 15.92 | 0 | On |
| 29 May 2026 | 86.40 BRL | -0.7% | 80.94 BRL | 47.98 BRL | -0.08 | 19.59 | 1 | On |
| 22 May 2026 | 87.03 BRL | -2.7% | 79.89 BRL | 47.54 BRL | -0.32 | 19.53 | 45 | On |
| 15 May 2026 | 89.46 BRL | 0.0% | 78.71 BRL | 47.10 BRL | -0.56 | 22.98 | 0 | On |
| 8 May 2026 | 89.46 BRL | 15.8% | 77.46 BRL | 46.66 BRL | -0.78 | 19.30 | 11 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.